ID
32574
Description
Study ID: 106837 Clinical Study ID: HZA106837 Study Title: A Long-Term, Randomized, Double-Blind, Parallel Group Study of Fluticasone Furoate/GW642444 Inhalation Powder Once-Daily and Fluticasone Furoate Inhalation Powder Once-Daily in Subjects with Asthma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01086384 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone furoate/vilanterol Trade Name: Relvar Study Indication: Asthma
Keywords
Versions (2)
- 11/7/18 11/7/18 -
- 12/7/18 12/7/18 -
Copyright Holder
GSK group of companies
Uploaded on
November 7, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
A Parallel Group Study of Fluticasone Furoate/Vilanterol in Subjects with Asthma - 106837
Liver Event: Medical Conditions
- StudyEvent: ODM
Description
Drug related liver disease conditions
Description
Other Liver Disease Conditions Entry
Description
Other medical conditions
Description
16. Drug allergies
Data type
text
Description
17. Rheumatoid arthritis
Data type
text
Description
18. Psoriasis
Data type
text
Description
19. Thyroid Disease
Data type
text
Description
20. Inflammatory Bowel disease
Data type
text
Description
21. Lupus
Data type
text
Description
22. Sjogren's Syndrome
Data type
text
Description
23. Vitiligo
Data type
text
Similar models
Liver Event: Medical Conditions
- StudyEvent: ODM